<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610985</url>
  </required_header>
  <id_info>
    <org_study_id>2D/3D hysterectomy</org_study_id>
    <nct_id>NCT02610985</nct_id>
  </id_info>
  <brief_title>2-D and 3-D Laparoscopic Hysterectomy</brief_title>
  <official_title>3-dimensional Versus Conventional Laparoscopy in Patients Undergoing Total Hysterectomy for Benign Disease - A Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      No randomised trials have been conducted, and only a single retrospective study exists
      comparing 3D and 2D laparoscopic hysterectomy. In that study, operative time for hysterectomy
      was significantly lower for 3D compared to 2D conventional laparoscopy. Complication rates
      were similar for the two groups. Thus, although one out of nine women is hysterectomized and
      although laparoscopy is one of the recommended routes of surgery, evidence whether to choose
      2D laparoscopy, 3D laparoscopy is sparse.

      Objective:

      To compare pain and recurrence to usual activity level. Secondary to compare complications
      during the operation, postoperative complications, time to return to work, length of hospital
      stay and operative time.

      Design:

      Investigator-initiated, blinded, randomised controlled trial.

      Intervention description:

      Operative procedures follow the same principles and the same standard whether the surgeon's
      vision is 2D or 3D.

      Trial size Roskilde/Herlev Hospital, Denmark:

      200 patients in each arm of the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score on SF 36 psychical health survey 6 weeks after surgery</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain (VAS score) assessed immediately at return to the gynaecological unit (about 5 hours postoperatively) and (VAS score) in the morning days 1-3 postoperatively.</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major complications during the operation, postoperative complications</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor complications during the operation, postoperative complications</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on SF 36 mental health survey 6 weeks after surgery</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Fibroma, Bleeding</condition>
  <arm_group>
    <arm_group_label>2-Dimensional laparoscopic hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>traditional 2-D laparoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-Dimensional laparoscopic hysterectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>experimental 3-D laparoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3-D laparoscopy</intervention_name>
    <description>3-D laparoscopy</description>
    <arm_group_label>3-Dimensional laparoscopic hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2-D laparoscopy</intervention_name>
    <description>2-D laparoscopy</description>
    <arm_group_label>2-Dimensional laparoscopic hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients referred for laparoscopic hysterectomy with or without bilateral
             salpingectomy or bilateral salpingooophorectomy for benign indications.

        Exclusion Criteria:

          -  Women not suitable for laparoscopic hysterectomy including:

               -  Ultrasound appraisal of uterus weight &gt; 1000 gram

               -  Need for prolapse surgery and therefore indication for vaginal hysterectomy.

          -  Inability to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elise Hoffmann, MD</last_name>
    <phone>+45 20252017</phone>
    <email>elisehoffmann78@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sjaellands Univercety Hospital</name>
      <address>
        <city>Roskilde</city>
        <state>Zealand</state>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise Hoffmann, MD</last_name>
      <phone>20252017</phone>
      <email>elisehoffmann78@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>April 1, 2018</last_update_submitted>
  <last_update_submitted_qc>April 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zealand University Hospital</investigator_affiliation>
    <investigator_full_name>Elise Hoffmann</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Imaging, Three-Dimensional</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>laparoscopic hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

